Stephen R Brady Tempest Therapeutics, Inc. (TPST) insider trading activity

TPST Quotes by TradingView

Stephen R Brady is President and CEO of Tempest Therapeutics, Inc.. Currently has a direct ownership of 46,376 shares of TPST, which is worth approximately $67,245. The most recent transaction as insider was on Jul 03, 2024, when has been sold 35,000 shares (Common Stock) at a price of $2.11 per share, resulting in proceeds of $73,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.4K
n/a 3M change
n/a 12M change
Total Value Held $67,245

Stephen R Brady Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2024
BUY
Open market or private purchase
$73,850 $2.11 p/Share
35,000 Added 43.01%
46,376 Common Stock

Also insider at

BCEL
Atreca, Inc. Healthcare
Director
SRB

Stephen R Brady

President and CEO
South San Francisco, CA

Track Institutional and Insider Activities on TPST

Follow Tempest Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPST shares.

Notify only if

Insider Trading

Get notified when an Tempest Therapeutics, Inc. insider buys or sells TPST shares.

Notify only if

News

Receive news related to Tempest Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPST